Equity Research
William Blair research analyst Arjun Bhatia was quoted in Investor’s Business Daily, where he shared his outlook for cloud software developer Twilio.
"Twilio appears to be turning a corner and is beginning to see sustained improvements across the business, primarily fueled by product innovation in areas like personalization, real-time data analytics, and message deliverability," Bhatia wrote on his note to investors that was cited by the publication.
Stay up-to-date with the latest William Blair news and insights
William Blair initiated research coverage of Altimmune, Inc. (ALT $5.91), BioAge Labs, Inc. (BIOA $4.18), Corbus Pharmaceuticals Holdings, Inc. (CRBP $7.50), Skye Bioscience, Inc. (SKYE $2.89), Structure Therapeutics, Inc. (GPCR $21.09), Terns Pharmaceuticals, Inc. (TERN $3.71), and Zealand Pharma A/S (ZEAL-CSE DKK 719.00).
In this episode of William Blair Thinking Presents, global services analyst Andrew Nicholas, CPA, discusses findings from his team’s extensive inaugural survey of accounting services executives, covering industry dynamics such as organic revenue growth, technology use, and M&A trends.
Dr. Carey W. King from the University of Texas at Austin delves into the intricate relationship between energy systems, the economy, and the environment, exploring his innovative HARMONEY Model and discussing the critical role of energy in shaping macroeconomic policies and future sustainability.
Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.
For disclosure information, please visit www.williamblair.com/disclosures
